23.93 USD
↗ 0.03 (0.13%)AT CLOSE (03:59 PM EST)
Neurogene, Inc. Common Stock (NGNE) is currently trading at $23.93. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest NGNE is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 13, 2026.